GH
GH
US40131M1099
Guardant Health, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
22.47B EUR
20.05B EUR
12.15B EUR
13.34B EUR
Enterprise Value
22.86B EUR
20.69B EUR
12.86B EUR
14.68B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-400.71x
--
--
--
Price to Sales
19x
16.94x
11.25x
17.14x
Price to Book
--
--
--
--
EV/Revenue
19.32x
17.49x
11.91x
18.85x
EV/EBITDA
-53.1x
--
--
--
Price to FCF (P/FCF)
844.66x
--
--
--
EV/FCF
859.21x
--
--
--
FCF Yield
0.12%
-1.2%
-1.95%
-1.24%
ende